申请人:Guillemont Jérôme Emile Georges
公开号:US20100063026A1
公开(公告)日:2010-03-11
The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib):
including any stereochemically isomeric form thereof,
a pharmaceutically acceptable salt thereof, a N-oxide form thereof or a solvate thereof. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
本发明涉及根据一般式(Ia)或式(Ib)的新型取代喹啉衍生物:包括其任何立体化异构体、其药学上可接受的盐、其N-氧化物形式或其溶剂合物。所述化合物用于治疗细菌感染。还声明了一种包含药学上可接受的载体和所述化合物的治疗有效量作为活性成分的组合物,所述化合物或组合物用于制造治疗细菌感染的药物以及制备所述化合物的方法。